CC
Commodore Capital Portfolio holdings
AUM
$2.05B
1-Year Est. Return
118.14%
1 Year Est. Return
+118.14%
AUM
$2.05B
AUM Growth
+$632M
(+45%)
Holding
40
Top Buys
| 1 | +$70.9M | |
| 2 | +$55.4M | |
| 3 | +$50M | |
| 4 |
Terns Pharmaceuticals
TERN
|
+$42.8M |
| 5 |
Assembly Biosciences
ASMB
|
+$25.6M |
Top Sells
| 1 | +$56.5M | |
| 2 | +$51.4M | |
| 3 | +$36.1M | |
| 4 |
MindMed
MNMD
|
+$20.9M |
| 5 |
Vera Therapeutics
VERA
|
+$18.8M |
Sector Composition
| 1 | Healthcare | 99.61% |
| 2 | Financials | 0.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Merus
MRUS
$7.33B
| $332M | 16.2% |
3,525,000
|
|
||
2
Nuvalent
NUVL
$8.22B
| $121M | 5.91% |
1,400,000
+25,000
|
|
||
3
Xenon Pharmaceuticals
XENE
$3.37B
| $108M | 5.29% |
2,700,000
-325,000
|
|
||
4
Cogent Biosciences
COGT
$6.15B
| $104M | 5.08% |
7,250,000
+4,938,836
|
|
||
5
Enliven Therapeutics
ELVN
$1.11B
| $96.1M | 4.69% |
4,692,809
|
|
||
6
Agios Pharmaceuticals
AGIO
$1.6B
| $93.9M | 4.58% |
2,338,287
+13,287
|
|
||
7
Alkermes
ALKS
$4.82B
| $92.9M | 4.54% |
3,096,754
+646,754
|
|
||
8
Soleno Therapeutics
SLNO
$2.66B
| $91.3M | 4.46% |
1,350,000
+740,000
|
|
||
9
Relay Therapeutics
RLAY
$1.35B
| $88.7M | 4.33% |
17,000,000
+3,650,000
|
|
||
10
Celldex Therapeutics
CLDX
$1.86B
| $78.3M | 3.82% |
3,028,335
-421,665
|
|
||
|
CNTA
11
Centessa Pharmaceuticals
CNTA
$4.02B
| $69.1M | 3.37% |
2,850,000
-448,289
|
|
||
12
Viridian Therapeutics
VRDN
$3.11B
| $69.1M | 3.37% |
3,200,000
-1,675,000
|
|
||
13
Protagonist Therapeutics
PTGX
$5.77B
| $68.1M | 3.32% |
1,025,000
-50,000
|
|
||
14
Pharvaris
PHVS
$1.56B
| $60.3M | 2.95% |
2,418,476
+507,043
|
|
||
15
Cidara Therapeutics
CDTX
$6.92B
| $56M | 2.73% |
585,000
-590,000
|
|
||
16
Amylyx Pharmaceuticals
AMLX
$1.44B
| $55.4M | 2.7% |
+4,075,478
|
|
||
17
Tyra Biosciences
TYRA
$1.22B
| $47.2M | 2.31% |
3,375,000
+275,000
|
|
||
|
18
Terns Pharmaceuticals
TERN
$4.24B
| $42.8M | 2.09% |
+5,700,000
|
|
||
19
Kymera Therapeutics
KYMR
$6.32B
| $42.5M | 2.07% |
750,000
|
|
||
|
20
MindMed
MNMD
$1.24B
| $38M | 1.86% |
3,225,000
-1,775,000
|
|
||
21
Nurix Therapeutics
NRIX
$1.93B
| $34.9M | 1.71% |
3,780,055
-168,598
|
|
||
|
ORKA
22
Oruka Therapeutics
ORKA
$1.46B
| $33.7M | 1.65% |
1,753,054
+333,340
|
|
||
23
Spyre Therapeutics
SYRE
$2.67B
| $33.3M | 1.63% |
1,988,084
|
|
||
|
DRUG
24
Bright Minds Biosciences
DRUG
$631M
| $30.3M | 1.48% |
500,000
|
|
||
|
25
Assembly Biosciences
ASMB
$568M
| $25.6M | 1.25% |
+1,000,000
|
|